GPR161 and neoplasm: Moreover, the lack of 1q loss events among GPR161 wild-type MBSHH tumors and the preferential mode of GPR161 inactivation, either focal or via cnLOH, suggests that 1q harbors dose-sensitive genes that might restrict MBSHH tumor development.